ETHYL N-[(4-METHYLBENZENESULFONYL)METHYL]CARBAMATE, 95.0%, 500mg

3-Bromopyridine-2,6-diamine, 95.0%, 25g

2-Chloro-4-pyrrolidin-1-ylpyrimidine, 97.0%, 5g

Hexadecyl Palmitate>97.0%(GC)25g

2-Bromo-5-hydroxybenzoic acid, 97.0%, 500g

18-Bromo-1-octadecene>93.0%(GC)5g

2-Chloro-n-(1-cyanocyclohexyl)-n-methylacetamide, 97%, 250mg

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 1.00 µm, 1 Piece(s)

1-(3-Bromo-5-fluorophenyl)ethanone, 95.0%, 5g

(2-Chloro-3-fluoro-6-methoxyphenyl)boronic acid, 98%, 1g

1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one, 97%, 100mg

Diethyl N-(tert-Butoxycarbonyl)phosphoramidate, 95%, 100mg

5-Bromo-2-nitropyridin-3-ol, 95.0%, 25g